Background: The purpose of this study was to determine the relationship between calcifi cations in the thyroid gland and malignant thyroid lesions. Methods: From June 2005 -May 2010, 169 patients, who had been operated on for thyroidectomy, were evaluated. The demographic fi ndings were analyzed with regard to ultrasonographic and histopathologic calcifi cations. The relationship between calcifi cations and malignant and benign thyroid lesions was statistically determined by SPSS 10.01 version of Z-test and Chi-square test. Results: Microcalcifi cations were found in 54 patients (31.95 %). Macrocalcifi cation was found in one patient (0.59 %). Malignancy was determined in 29 patients (17.16 %). The rate of malignancy in patients with calcifi cations was 17/55 (30.9 1%). The diagnosis was nodular colloidal goiter in 38 patients (38/55, 69.09 %) with calcifi cations. The rate of calcifi cation in malignant patients was 17/29 (58.62 %). The rate of malignancy in patients without calcifi cation was 12/114 (10.52 %). The difference between the rate of malignancy in patients with calcifi cation and the rate of malignancy in patients without calcifi cation was statistically signifi cant (Z-test, p < 0.001). Conclusion: Microcalcifi cations of the thyroid gland could predict malignant thyroid disease. They should be strictly evaluated by all thyroid cancer diagnostic modalities and surgical treatment should also be considered (Tab. 4, Ref. 29 The high prevalence of thyroid nodules and the risk of malignancy are serious problems in thyroid surgery. Approximately 3 -7 % of adult populations have palpable thyroid nodules; however, only 5 % of clinically detected nodules are malignant (1, 2, 3).
The high prevalence of thyroid nodules and the risk of malignancy are serious problems in thyroid surgery. Approximately 3 -7 % of adult populations have palpable thyroid nodules; however, only 5 % of clinically detected nodules are malignant (1, 2, 3) .
Although the incidence of well-differentiated thyroid carcinoma has been reported in up to 36 % in autopsy series, it is proven histopathologically in about 10 % of patients who undergo surgery. Fine-needle aspiration cytology samples are insuffi cient for the diagnosis, and up to 28 % of the patients studied showed nondiagnostic and false positive results (4, 5) .
Patients with calcifi cations in the thyroid gland are still a clinical dilemma. When a calcifi cation is detected in the gland, a question arises as to whether this is a predictive sign for malignancy or not. Microcalcifi cations were reported in 60 % of malignant nodules (6). The specifi city of microcalcifi cation for malignancy increases in young patients who exhibit single nodules with a snow-storm pattern on ultrasound (7). On the other hand, though the specifi city of microcalcifi cations increase to 95 % for papillary cancer, the sensitivity is low; 29-59 % of papillary carcinomas are seen with microcalcifi cations (8).
Calcifi cations may be easily recognized by thyroid ultrasonography (US) or histopathological examination. Although high frequency ultrasound transducers increased the sensitivity of ultrasonography, they are not suffi cient to determine the malignancy. Calcifi cations can be in macro-or microcalcifi cation form. Macrocalcifi cations are greater than 2 mm, and are commonly seen due to trauma or infl ammatory process; they are rarely associated with medullary cancer. Microcalcifi cations are less than 2 mm and have been described in literature as "snowstorm," "peripheral," "fi ne stippled psammomatous (FSP)," "fi ne,", "punctuate," "gross," and "coarse". Furthermore, these quantifi cations are not specifi c for malignancy (1, 7) .
While most of the authors agree that microcalcifi cation is a predictive factor for malignant thyroid lesion, there are some authors who disagree.
In this study, we tried to determine the relationship between calcifi cations in the thyroid gland and thyroid malignancy.
Patients and methods
Study participants included 178 who had undergone thyroidectomy between June 2005 and May 2010 at Ondokuz Mayıs University, Faculty of Medicine, Department of Surgery. All 178 patients were operated upon by a single surgeon. The demographic data and the ultrasonographic and histopathologic fi ndings were analyzed. The ultrasonographic examination was made by using the Toshiba Aplio 80 apparatus, with a 7.5 mHz linear probe. The calcifi cations were quantifi ed as peri-and intranodular, and micro-(<2 mm) and macrocalcifi cations (>2 mm). The histopathologic evaluation was made with haematoxylin-eosin staining. The blue-violet amorphous stainings of fi ne, coarse, peripheral and psammomatous types, inside and around the thyroid nodules were defi ned as calcifi cations.
Nine patients, whose ultrasonographic and histopathologic fi ndings could not be determined, were excluded. In 135 of the remaining 169 patients, both ultrasonographic and histopathological fi ndings were analyzed. In 34 patients, only histopathologic fi ndings were analyzed because the ultrasonographic fi ndings were not available. The relationship between the calcifi cations was determined using ultrasonography and/or histopathology, and the malignancy was determined by fi ne-needle aspiration biopsy or surgical specimen, and was retrospectively and statistically analyzed. The differences and the signifi cances of the results were analyzed using the SPSS 10.01 verrsion of the Z-test and the Chisquare test in SPSS 10.01 version.
Results
Of the 178 participants, 44 patients (26.04 %) were male and 125 (73.96 %) were female. The mean age of patients was 48.23 ±13.087 (age range 20 -94). Ten males and 19 females were diagnosed with thyroid cancer (Tab. 1). The difference between the rates of malignancy in males and females was not statistically signifi cant (p = 0.255) but the rate of malignancy is higher in males (22.74 % for males versus 15.20 % for females). However, the rate of nodules in males who had undergone surgery was lower when compared with females (26.04 % for males versus 73.96 % for females).
Ten patients who had undergone surgery at another center and diagnosed with nodular goiter were referred to our hospital with the histopathological diagnosis of malignancy. In these patients, due to insuffi cient ultrasonographic evaluation and unavailable preoperative ultrasonographic fi ndings, only the histopathologic fi ndings were analyzed with regard to the aspect of calcifi cations.
Out of 135 patients, calcifi cations were determined in 34 patients (25.19 %) in whom both ultrasonographic and histopathologic fi ndings were evaluated. Of these 34 patients, in 21 patients (61.76 %), only the histopathologic fi ndings were evaluated (Tab. 2).
Microcalcifi cations were determined in 54 of 169 patients (31.95 %), a macrocalcifi cation was determined in one patient (0.59 %), and malignancy was determined in 29 patients (17.16 %). The histopathologic diagnosis of the patient with macrocalcifi cation was benign (Tab. 3). Fourteen of 20 patients (70 %) with papillary cancer had histopathologic calcifi cations (Tab. 4).
The rate of malignancy in patients with calcifi cations was 17/55 (30.91%). Of the 55 patients with calcifi cations, 38 (69.09 %) were diagnosed with "nodular colloidal goiter" (Tab. 3). The rate of calcifi cation in patients with malignancy was 17/29 (58.62 %). The rate of malignancy in patients without calcifi cation was 12/114 (10.52 %) (Tab. 3). The difference between the rate of malignancy in patients with calcifi cation and the rate of malignancy in patients without calcifi cation was statistically signifi cant (z-test, p <0.001).
Discussion
Thyroid cancer is a relatively uncommon disease which constitutes about 0.5-2 % of all malignancies (9). Calcifi cation detected by thyroid ultrasound represents a risk factor for malignancy but it is of limited use as a sole marker of malignancy (10). Ultrasound is an ideal imaging modality of detecting the thyroid nodules. It is easy to perform, widely available, non-invasive, and affordable. The advantages of using ultrasound in the diagnosis of thyroid disease (both malign and benign) are that it allows for the detection and characterization of thyroid malignancies, cervical nodal metastases, and loco-regional recurrence, as well as provides image-guided biopsy for fi ne-needle aspiration cytology (11, 12) . On the other hand, ultrasonographic fi ndings of thyroid cancers are well described in literature. Calcifi cation, irregular shape, solid hypoechogenity, absence of halo, intranodular hypervascularity and changing margin (blurred or ill-defi ned), alone or in combination of two or more are reported as predictive factors of thyroid cancers (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
Calcifi cation in the thyroid can be detected by US or histopathological examinations. Studies have found that 16.95-78.8 % of patients have calcifi cations in their thyroid (1, 6, 10, 25) . In our study, the rate of calcifi cation was found to be 32.54 % by US or histopathological examinations. These results correlated with the fi ndings presented in literature. In our study, the rate of calcifi cation in malignant lesions was 58.62 %. This is a signifi cantly higher number than the rate of overall calcifi cations. However, the rate of malignancy in calcifed lesions is not as high (only 30.91 %). Therefore, when a calcifi cation is determined, malignancy should be suspected; however that does not mean that all calcifi cations are malignant.
Macrocalcifi cations of the thyroid have been reported unrelated to malignancies, except with regard to medullary cancer. In literature, microcalcifi cations are classifi ed as "snowstorm," "peripheral," "fi ne stippled psammomatous (FSP)," "fi ne," and "punctuate" (7, 14, 15, 16, 25, 26) . All types of microcalcifi cations have been reported as predictive factors for thyroid cancer. Commonly reported "coarse," "dysmorphic," or "curvilinear" calcifi cations indicate benign lesions of the thyroid gland (2) . Additionally, Park (9) found that interruptions of peripheral calcifi cations were more common in malignant nodules (84%) vs. benign ones (53 %). Furthermore, the thickening of peripheral calcifi cations was seen more frequently in malignant nodules (64 % vs 11 %) than in benign ones.
Most of the authors agree that calcifi cation is a predictive factor for thyroid malignancies (1, 7, 8, 9, 10, 25, 26, 27, 28) , while a few authors disagree (6, 29). According to Chan (11) , hypoechoic texture (86 %), microcalcifi cations (42 %), well-defi ned margins (47 %), and intrinsic hypervascularity (69 %) are common sonographic features of papillary carcinoma. He also found the rate of microcalcifi cations to be 69 % and the rate of coarse calcifi cations 17 %. In our study, the rate of microcalcifi cations was 31.95 %. Microcalcifi cations associated with other fi ndings were highly specifi c for thyroid malignancies but they were only present in half of the malignancies. When positive fi ndings of malignancy are studied in parallel, sensitivity and specifi city will increase to 81 % (12) .
Chen reported (10) that the incidence of calcifi cation in patients with thyroid carcinoma was signifi cantly higher than in those with benign lesions (54.17 % vs 26.87 %; p < 0.005). Chammas (1) has found that microcalcifi cations were highly specifi c for malignancy and were present in 61 % of the malignant nodules (p =0.001). Wang (26) has reported that in his series of 332 cases, FSP calcifi cation was more signifi cant in malignant nodules than was non-FSP calcifi cation (p = 0.001). González (27) has showed that most cases with microcalcifi cations were malignant compared to cases without calcifi cations (60 % vs 1.7 %, p < 0.001). Khoo's study (28) shows that intrathyroideal calcifi cation with malignancy occurred at a rate of 59.2 %.
Wong has reported that fi ne calcifi cation is seen in papillary carcinoma in 25-40 % of cases (2) . As a predictive sign of malignancy, the specifi city and positive predictive value of calcifi cation were reported as 93 % and 70 %, respectively (6). Our study found the calcifi cation rate to be 70 % in papillary cancer. The rate of calcifi cations in other types of thyroid cancer such as medullary, Hurthle cell or anaplastic carcinoma is higher; only four patients with these types of concerns were reported in our series (Table 2) . If greater numbers of patients could be analyzed in future studies, the statistical signifi cance of calcifi cations could be determined.
The sensitivity and specifi city of microcalcifi cations in thyroid malignancies has been found to be 32.28-78.80 % and 61.30-100 % (3, 6, 7, 10, 12, 25) . However, macrocalcifi cation has been found to be less sensitive (9.7 %) (25) .
In our study, calcifi cations of thyroid malignancies are found approximately six times more often than those of benign diseases (p <0.001). This fi nding also correlates with literature.
In conclusion, microcalcifi cation of the thyroid gland is a predictive factor for malignancy. When detected, malignancy should be suspected and all diagnostic modalities including fi ne-needle aspiration biopsy and surgical treatment should be considered.
